This guide is written from a family-caregiver perspective. The site operator is not a medical professional. It provides general education and preparation questions, not an individual diagnosis, treatment plan or clearance.
Compare the proposed procedure, not an internet ranking
Transforaminal and interlaminar describe epidural routes, but route is only one component of care. The assessment, level, medicine, anatomy and procedural plan also matter. A published success rate or an MRI term cannot determine the appropriate approach for a particular person.
Ask why this option is being proposed
Request expected benefit, uncertainty, risks and reasonable alternatives in plain language. In the United States, corticosteroids are not FDA-approved for epidural use and labeling warns about serious neurological events. Discuss this during consent; a procedure performed with imaging is not risk-free.
Keep preparation and outcome review clear
Follow the actual service’s instructions about medicines, food, transport and activity. Ask what symptoms need immediate contact and when routine feedback is expected. Do not change prescribed medicines, test a weak leg or provoke symptoms to produce a cleaner result record.
Compare the case-specific proposal
Use these prompts to prepare questions and arrangements. They do not diagnose a condition, determine coverage or clear an activity.
- What to record
- Diagnosis explained, proposed route and level, medicine, goals and the follow-up plan.
- What to ask
- Why this approach for my situation and what are its limits, risks and alternatives?
- Next action and owner
- Ask the procedural clinician to explain the decision; neither an MRI word nor a published success rate chooses a route for an individual. Write down who will act and when to follow up.
Keep personal records private. You can use the visit preparation organizer to arrange questions; do not post identifying health information in comments.
Primary information
DailyMed: corticosteroid labeling and epidural warning
Editorial rewrite: October 21, 2026. Replaced the previous body and removed unsupported experience claims or universal decision rules. This is an editorial update, not a medical-professional review.